Literature DB >> 23999868

Expression machinery of GM4: the excess amounts of GM3/GM4S synthase (ST3GAL5) are necessary for GM4 synthesis in mammalian cells.

Satoshi Uemura1, Shinji Go, Fumi Shishido, Jin-ichi Inokuchi.   

Abstract

The ganglioside GM4 is a sialic acid-containing glycosphingolipid mainly expressed in mammalian brain and erythrocytes. GM4 is synthesized by the sialylation of galactosylceramide (GalCer), while the ganglioside GM3 is synthesized by the sialylation of lactosylceramide (LacCer). Recently, the enzyme GM3 synthase was found to be responsible for the synthesis of GM4 in vitro and in vivo, yet the mechanism behind GM4 expression in cells remains unclear. In this study, we attempted to establish GM4-reconstituted cells to reveal the regulation of GM4 synthesis. Interestingly, GM4 was not detected in RPMI 1846 cells expressing LacCer, GalCer, and GM3. Similarly, GM4 was not detected in CHO-K1 cells, even when such cells expressing LacCer and GM3 were stably transfected with the GalCer synthase (GalCerS) gene. GM4 became detectable only when the GM3/GM4 synthase (GM3/GM4S, ST3GAL5) gene was overexpressed in either RPMI 1846 or CHO-K1/GalCerS cells. A mutant of the B16 melanoma cell line, GM-95, lacks GlcCer and LacCer, due to an absence of GlcCer synthase, but carries endogenous LacCer synthase and GM3/GM4S. GalCer became detectable after transfection of GalCerS into GM95 cells, but the GM95/GalCerS reconstituted cells did not express GM4, indicating that competition between the substrates LacCer and GalCer for GM3/GM4S does not cause the failure of GM4 synthesis. These results suggest that the expression machinery of GM4 under physiological conditions is independent from that of GM3.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23999868     DOI: 10.1007/s10719-013-9499-1

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  25 in total

1.  [FURTHER GANGLIOSIDES FROM THE HUMAN BRAIN].

Authors:  R KUHN; H WIEGANDT
Journal:  Z Naturforsch B       Date:  1964-03       Impact factor: 1.047

2.  Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome.

Authors:  A Chiba; S Kusunoki; H Obata; R Machinami; I Kanazawa
Journal:  Brain Res       Date:  1997-01-16       Impact factor: 3.252

3.  Sialylation and sulfation of lactosylceramide distinctly regulate anchorage-independent growth, apoptosis, and gene expression in 3LL Lewis lung carcinoma cells.

Authors:  Satoshi Uemura; Kazuya Kabayama; Mariko Noguchi; Yasuyuki Igarashi; Jin-Ichi Inokuchi
Journal:  Glycobiology       Date:  2002-12-17       Impact factor: 4.313

4.  Ganglioside GM3 participates in the pathological conditions of insulin resistance.

Authors:  Seiichi Tagami; Jin-ichi Inokuchi Ji; Kazuya Kabayama; Haruhiko Yoshimura; Futoshi Kitamura; Satoshi Uemura; Chie Ogawa; Atsushi Ishii; Masaki Saito; Yoshinori Ohtsuka; Shinji Sakaue; Yasuyuki Igarashi
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

5.  Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.

Authors:  S Watarai; Y Kushi; R Shigeto; N Misawa; Y Eishi; S Handa; T Yasuda
Journal:  J Biochem       Date:  1995-05       Impact factor: 3.387

6.  The cytoplasmic tail of GM3 synthase defines its subcellular localization, stability, and in vivo activity.

Authors:  Satoshi Uemura; Sayaka Yoshida; Fumi Shishido; Jin-ichi Inokuchi
Journal:  Mol Biol Cell       Date:  2009-05-06       Impact factor: 4.138

7.  Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling.

Authors:  Akikazu Fujita; Jinglei Cheng; Minako Hirakawa; Koichi Furukawa; Susumu Kusunoki; Toyoshi Fujimoto
Journal:  Mol Biol Cell       Date:  2007-03-28       Impact factor: 4.138

8.  Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti.

Authors:  Misato Yoshikawa; Shinji Go; Kotaro Takasaki; Yasuhiro Kakazu; Mitsuru Ohashi; Masakazu Nagafuku; Kazuya Kabayama; Junji Sekimoto; Shun-ichi Suzuki; Kazutaka Takaiwa; Takashi Kimitsuki; Nozomu Matsumoto; Shizuo Komune; Daisuke Kamei; Masaki Saito; Michihiro Fujiwara; Katsunori Iwasaki; Jin-ichi Inokuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

9.  A mouse B16 melanoma mutant deficient in glycolipids.

Authors:  S Ichikawa; N Nakajo; H Sakiyama; Y Hirabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  Ganglioside glycosyltransferases organize in distinct multienzyme complexes in CHO-K1 cells.

Authors:  Claudio G Giraudo; Hugo J F Maccioni
Journal:  J Biol Chem       Date:  2003-08-04       Impact factor: 5.157

View more
  5 in total

1.  Identification of a new liver-specific c-type mRNA transcriptional variant for mouse ST3GAL5 (GM3/GM4 synthase).

Authors:  Fumi Shishido; Satoshi Uemura; Takahiro Nitta; Jin-Ichi Inokuchi
Journal:  Glycoconj J       Date:  2017-08-14       Impact factor: 2.916

2.  Ganglioside Extraction, Purification and Profiling.

Authors:  Mitchell J Porter; Gao-Lan Zhang; Ronald L Schnaar
Journal:  J Vis Exp       Date:  2021-03-12       Impact factor: 1.355

Review 3.  Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2.

Authors:  Emma J Arsenault; Colin M McGill; Brian M Barth
Journal:  Neuromolecular Med       Date:  2021-02-05       Impact factor: 4.103

Review 4.  The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology.

Authors:  Marjolaine Hugonnet; Pushpita Singh; Quentin Haas; Stephan von Gunten
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

5.  Glycation Interferes with the Expression of Sialyltransferases in Meningiomas.

Authors:  Philipp Selke; Kaya Bork; Tao Zhang; Manfred Wuhrer; Christian Strauss; Rüdiger Horstkorte; Maximilian Scheer
Journal:  Cells       Date:  2021-11-25       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.